These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25033727)

  • 1. GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma.
    Edelman MJ; Feliciano J; Yue B; Bejarano P; Ioffe O; Reisman D; Hawkins D; Gai Q; Hicks D; Serrero G
    Hum Pathol; 2014 Sep; 45(9):1893-9. PubMed ID: 25033727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
    Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
    Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
    Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
    Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
    Tkaczuk KHR; Hawkins D; Yue B; Hicks D; Tait N; Serrero G
    Clin Breast Cancer; 2020 Jun; 20(3):220-227. PubMed ID: 31928925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas.
    Yamamoto Y; Goto N; Takemura M; Yamasuge W; Yabe K; Takami T; Miyazaki T; Takeuchi T; Shiraki M; Shimizu M; Adachi S; Saito K; Shibata Y; Nakamura N; Hara T; Serrero G; Saito K; Tsurumi H
    Clin Chim Acta; 2017 Oct; 473():139-146. PubMed ID: 28823651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can serum progranulin level be used as a prognostic biomarker in non-small cell lung cancer?
    Taci Hoca N; Ünsal E; Murat K; Ertürk A; Çapan N
    Monaldi Arch Chest Dis; 2022 Nov; 93(3):. PubMed ID: 36382807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
    Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
    Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.
    Zhang J; Chen N; Qi J; Zhou B; Qiu X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1441-9. PubMed ID: 24770635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.
    Abrhale T; Brodie A; Sabnis G; Macedo L; Tian C; Yue B; Serrero G
    BMC Cancer; 2011 Jun; 11():231. PubMed ID: 21658239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients.
    Eckstein M; Lieb V; Jung R; Sikic D; Weigelt K; Stöhr R; Geppert C; Weyerer V; Bertz S; Serrero G; Yue B; Hartmann A; Wullich B; Taubert H; Wach S
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer: New Prognostic Factors.
    Naumnik W; Panek B; Ossolińska M; Naumnik B
    Adv Exp Med Biol; 2019; 1150():11-16. PubMed ID: 30357709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of Theranostic Target Mining in the Development of Novel Diagnostic and Therapeutic Products in Oncology: Progranulin/GP88 as a Therapeutic and Diagnostic Target for Breast and Lung Cancers.
    Serrero G
    Rinsho Byori; 2016 Nov; 64(11):1296-1309. PubMed ID: 30695312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects.
    Tkaczuk KR; Yue B; Zhan M; Tait N; Yarlagadda L; Dai H; Serrero G
    Breast Cancer (Auckl); 2011; 5():155-62. PubMed ID: 21792312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.
    Cho A; Hur J; Hong YJ; Lee HJ; Kim YJ; Hong SR; Suh YJ; Im DJ; Kim YJ; Lee JS; Shim HS; Choi BW
    Tumour Biol; 2016 Mar; 37(3):3205-13. PubMed ID: 26432331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
    Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
    Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
    Pøhl M; Olsen KE; Holst R; Donnem T; Busund LT; Bremnes RM; Al-Saad S; Andersen S; Richardsen E; Ditzel HJ; Hansen O
    Acta Oncol; 2016; 55(2):167-77. PubMed ID: 26057535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progranulin/GP88, A Complex and Multifaceted Player of Tumor Growth by Direct Action and via the Tumor Microenvironment.
    Serrero G
    Adv Exp Med Biol; 2021; 1329():475-498. PubMed ID: 34664252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.